Oncology Institute Inc
NASDAQ:STLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Oncology Institute Inc (STLN) under the Base Case is 6.56 USD per share.
Compared with the current market price of 4.34 USD, the stock appears
Undervalued by 34% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -7.2% last year to 1% by 2033. Revenue grows about 29% a year over the next five years, above its five-year pace of 22%. The forecast years subtract value, so the estimate rests entirely on the years after 2033.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Oncology Institute Does
The Oncology Institute is a cancer care company that runs community-based oncology clinics and related services. It treats patients with cancer through medical oncology, radiation oncology, and other parts of cancer care, with doctors, nurses, and support staff working closely with local hospitals and referring physicians. Its main customers are patients, while its business relationships also include health plans and hospital systems that send patients into its care.
- Headquarters
- United States of America US
- Employees
- 641
- IPO date
- Mar 13, 2020
Earnings Waterfall
Oncology Institute Inc
What is the Intrinsic Value of one STLN stock?
The intrinsic value for Oncology Institute Inc (STLN) under the Base Case is 6.56 USD.
Is STLN stock undervalued or overvalued?
Compared with the current market price of 4.34 USD, the stock appears Undervalued by 34% .
